Introduction to Global Rivaroxaban Buyer Landscape Rivaroxaban is a leading oral anticoagulant drug widely prescribed for atrial fibrillation, venous thromboembolism prophylaxis, and coronary artery disease management across global healthcare systems. As a high-demand specialty pharmaceutical product available in API (Active Pharmaceutical Ingredient) and finished tablet dosage forms (10mg, 15mg, 20mg), it maintains consistent cross-border trade activity worldwide. Understanding the Rivaroxaban global buyers list is critical for pharmaceutical manufacturers, API suppliers, export firms, and medical supply distributors looking to establish compliant, long-term B2B trade partnerships. The global Rivaroxaban import market spans over 38 countries, with hundreds of active verified buyers operating across pharmaceutical distribution, generic drug manufacturing, hospital supply chains, and…